Neoleukin Therapeutics (NLTX) Stock Chart & Stock Price History $21.78 +0.01 (+0.05%) As of 08/1/2025 Add Compare Share Share Chart Stock AnalysisChartCompetitorsInsider TradesSEC FilingsTrendsBuy This Stock Neoleukin Therapeutics Stock Price Performance The Neoleukin Therapeutics (NLTX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 46.24%, with a year-to-date return of -5.18%. In the past month, the stock has increased 13.50%, reflecting recent market activity. As of the latest close, Neoleukin Therapeutics traded at $21.77 with a market cap of $204.59 million and volume of 69,132 shares. Five years ago, the stock traded at a split-adjusted price of $193.60, representing a 88.75% decrease over that period. At the time, it had a market cap of $376.03 million and a volume of 20,978 shares. Receive NLTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Neoleukin Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-4.14%1 Month Performance+13.50%3 Month Performance+41.43%Year-To-Date Performance-5.18%1 Year Performance-46.24%5 Year Performance-88.75% NLTX Stock Chart for Saturday, August, 2, 2025 NLTX Chart by TradingView Neoleukin Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/01/2025$21.68$21.77+0.42%$22.51$21.1669,132 shs$204.59 million07/31/2025$21.68$21.68$23.04$21.6078,279 shs$203.75 million07/30/2025$21.68$21.68$23.04$21.6078,279 shs$203.75 million07/29/2025$22.72$21.68-4.58%$23.04$21.6078,279 shs$203.75 million07/28/2025$22.72$22.72$23.17$22.0175,610 shs$213.52 million07/25/2025$23.09$22.81-1.21%$23.53$22.3596,399 shs$214.37 million07/24/2025$22.34$23.09+3.36%$23.88$22.26161,659 shs$217 million07/23/2025$22.34$22.34$23.50$22.31111,114 shs$209.95 million07/22/2025$22.34$22.34$23.50$22.31111,114 shs$209.95 million07/21/2025$22.34$22.34$23.50$22.31111,114 shs$209.95 million Get the Latest News and Ratings for NLTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Neoleukin Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/18/2025$22.54$22.60+0.27%$23.27$22.40135,052 shs$212.40 million07/17/2025$21.47$22.54+4.98%$22.66$21.2289,846 shs$211.83 million07/16/2025$22.26$21.47-3.55%$22.84$20.84142,891 shs$201.78 million07/15/2025$21.43$22.26+3.87%$22.82$19.98201,066 shs$209.20 million07/14/2025$21.43$21.43$22.20$21.23113,400 shs$201.40 million07/11/2025$21.26$21.26$21.44$20.21229,155 shs$199.80 million07/10/2025$20.28$21.26+4.83%$21.44$20.21229,155 shs$199.80 million07/09/2025$19.50$20.28+4.00%$20.80$19.6297,331 shs$190.59 million07/08/2025$20.09$19.50-2.94%$20.55$19.37221,816 shs$183.26 million07/07/2025$20.09$20.09$20.71$19.0175,550 shs$188.81 million07/04/2025$19.75$20.09+1.72%$20.71$19.0175,550 shs$188.81 million07/03/2025$19.19$19.75+2.92%$21.19$19.08240,714 shs$185.61 million07/02/2025$14.95$19.19+28.36%$21.19$14.651.35 million shs$180.35 million07/01/2025$16.16$14.95-7.49%$16.33$14.93205,629 shs$140.50 million Related Companies Immatics Stock Price Chart CorMedix Stock Price Chart ProKidney Stock Price Chart Oculis Stock Price Chart Xeris Biopharma Stock Price Chart Cronos Group Stock Price Chart AnaptysBio Stock Price Chart Upstream Bio Stock Price Chart GH Research Stock Price Chart Niagen Bioscience Stock Price Chart Receive NLTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Neoleukin Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NLTX) was last updated on 8/2/2025 by MarketBeat.com Staff From Our Partners379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredI warned you about Nvidia… now look what’s happeningNvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before t...Timothy Sykes | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | SponsoredTrump’s crypto advisor may have revealed the next big crypto opportunityWhile investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...Weiss Ratings | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neoleukin Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neoleukin Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NLTX Stock Alerts